F14. REDUCED DURATION MISMATCH NEGATIVITY ASSOCIATED WITH DECREASED GLUTAMATE+GLUTAMINE LEVEL IN SUBJECTS AT CLINICAL HIGH-RISK FOR PSYCHOSIS

BACKGROUND: Abnormal mismatch negativity (MMN), thought to be a putative marker of glutamatergic function, has been reported in non-Asian, first episode schizophrenia and clinical high-risk for psychosis (CHR) individuals as indicative of impairments in pre-attentive processes. However, reports of a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Schizophr Bull
Main Authors: Tang, Yingying, Zhang, TianHong, Wang, Junjie, Xu, LiHua, Qian, Zhenying, Cui, HuiRu, Seidman, Larry J, McCarley, Robert W, Keshavan, Matcheri S, Stone, William S, Niznikiewicz, Margaret, Wang, JiJun
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2018
Assuntos:
Abstracts
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5887943/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sby017.545
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares